Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

Summary Background Non‐alcoholic steatohepatitis (NASH) is a form of progressive fatty liver disease that is strongly associated with insulin resistance, which suggests that insulin sensitizing agents such as metformin may be beneficial for NASH. Aim To assess the effects of metformin on insulin s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2009-01, Vol.29 (2), p.172-182
Hauptverfasser:	LOOMBA, R., LUTCHMAN, G., KLEINER, D. E., RICKS, M., FELD, J. J., BORG, B. B., MODI, A., NAGABHYRU, P., SUMNER, A. E., LIANG, T. J., HOOFNAGLE, J. H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Biopsy Digestive system Fatty Liver - drug therapy Female Gastroenterology. Liver. Pancreas. Abdomen Humans Hypoglycemic Agents - therapeutic use Liver - drug effects Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Metformin - therapeutic use Middle Aged Other diseases. Semiology Pharmacology. Drug treatments Pilot Projects Statistics as Topic Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!